Search Results 7971-7980 of 37257 for oral

  1. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  2. Dental Specialties - Clinical trials

    Clinical trials are research studies that involve volunteer participants. These human studies help doctors better understand, diagnose, treat, and prevent ...

  3. Throat cancer - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...

  4. Cross-Variant Memory B Cell and T Cell Responses After COVID-19 mRNA Vaccine Booster - Mayo Clinic

    Preventative use of antibiotics (i.e. oral surgery) is not an exclusion criterion. Diagnosis of a cognitive disorder (e.g., Alzheimer's, Dementia). Anemia ...

  5. Immunogenetics of COVID-19 Immune Response - Mayo Clinic

    Preventative use of antibiotics (i.e. oral surgery) is not an exclusion criterion. Diagnosis of a cognitive disorder (e.g., Alzheimer's, Dementia). Anemia ...

  6. Surgery - Doctors - Mayo Clinic

    Christopher F. Viozzi, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...

  7. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients unable to take any prophylaxis are not eligible. Life expectancy ≥6 months; Ability to swallow oral medications. Exclusion Criteria: This study ...

  8. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    ... oral contraceptives; (2) tyrosine kinase inhibitors (TKIs) that have been discontinued greater than (>) 7 days prior to Cycle 1, Day 1, baseline scans must ...

  9. Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (the "Apact" Study) - Mayo Clinic

    ... oral agent hypothesized to inhibit multiple oncogenic pathways. In this article, we describe the design and rationale for the CanStem111P clinical trial, a ...

  10. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

    Able to swallow oral formulation of drugs. Signed and dated informed consent document for study participation. Willing to submit tissue, blood, stool ...